Greg Ball, PhD

Greg’s research on blinded safety monitoring procedures is being developed in collaboration with statistical and clinical scientists at several pharmaceutical companies (including AbbVie and Merck). Greg co-leads, with Mac Gordon, Scott Proestel, and Ellis Unger, the PHUSE Safety Analytics working group; he established, with Bill Wang, the ASA Biopharm Safety Monitoring working group; and he pioneered, with Susan Duke, Mengchun Li, and Jim Buchanan, the joint DIA-ASA Interdisciplinary Safety Evaluation (DAISE) scientific working group – to advocate for aggregate safety assessments and cross-disciplinary scientific engagement.